Ajer Jeffrey Robert

Insider profile

Performance

Overall performance
3.0

Performance over holding periods
3.0
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 18% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ajer Jeffrey Robert's trades of Biomarin Pharmaceutical Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-06-04 2024-06-04 PrS Proposed sale
34,634
363.38
US$2,283,926
34,634 363.38 US$2,283,926
2024-05-29 2024-05-29 PrS Proposed sale
84,389
435.83
US$185,101
84,389 435.83 US$185,101
2024-05-06 2024-05-02 PlS Planned sale
51,958 -10.7%
86.35
US$4,165,804
51,958 -10.7% 86.35 US$4,165,804
2024-05-02 2024-05-02 PrS Proposed sale
5,000
82.91
US$414,550
5,000 82.91 US$414,550
2024-03-07 2024-03-05 PlS Planned sale
4,000 -4.1%
87.07
US$348,280
4,000 -4.1% 87.07 US$348,280
2024-03-05 2024-03-05 PrS Proposed sale
4,000
87.07
US$348,280
4,000 87.07 US$348,280
2023-09-20 2023-09-18 S Sale
4,359 -11.3%
0.69
US$3,008
4,359 -11.3% 0.69 US$3,008
2023-08-17 2023-08-16 PlS Planned sale
5,000 -7.6%
90.00
US$450,000
5,000 -7.6% 90.00 US$450,000
2023-08-16 2023-08-16 PrS Proposed sale
5,000
90.00
US$450,000
5,000 90.00 US$450,000
2023-01-27 2023-01-25 PlS Planned sale
4,175 -9.2%
116.15
US$484,943
4,175 -9.2% 116.15 US$484,943
2023-01-27 2023-01-25 PlS Planned sale
44,825 -49.8%
115.65
US$5,184,191
44,825 -49.8% 115.65 US$5,184,191
2022-11-04 2022-11-02 PlS Planned sale
3,000 -6.8%
86.12
US$258,360
3,000 -6.8% 86.12 US$258,360
2022-09-26 2022-09-23 S Sale
4,198 -9.8%
3.16
US$13,266
4,198 -9.8% 3.16 US$13,266
2022-08-12 2022-08-11 PlS Planned sale
3,000 -6.4%
95.62
US$286,860
3,000 -6.4% 95.62 US$286,860
2022-05-31 2022-05-26 PlS Planned sale
1,308 -2.4%
78.94
US$103,254
1,308 -2.4% 78.94 US$103,254
2022-04-14 2022-04-13 PlS Planned sale
1,180 -2.1%
82.47
US$97,315
1,180 -2.1% 82.47 US$97,315
2022-03-24 2022-03-23 PlS Planned sale
6,129 -9.4%
81.78
US$501,230
6,129 -9.4% 81.78 US$501,230
2022-03-24 2022-03-22 PlS Planned sale
2,073 -3.1%
81.00
US$167,913
2,073 -3.1% 81.00 US$167,913
2021-10-28 2021-10-26 PlS Planned sale
2,739 -4.7%
73.60
US$201,590
2,739 -4.7% 73.60 US$201,590
2021-04-09 2021-04-08 PlS Planned sale
1,537 -2.6%
78.81
US$121,131
1,537 -2.6% 78.81 US$121,131
2021-04-01 2021-03-30 PlS Planned sale
1,652 -2.7%
74.79
US$123,553
1,652 -2.7% 74.79 US$123,553
2021-03-26 2021-03-24 PlS Planned sale
1,181 -1.9%
76.30
US$90,110
1,181 -1.9% 76.30 US$90,110
2021-03-19 2021-03-18 PlS Planned sale
1,308 -2.0%
77.99
US$102,011
1,308 -2.0% 77.99 US$102,011
2020-10-15 2020-10-14 PlS Planned sale
2,121 -3.3%
79.91
US$169,489
2,121 -3.3% 79.91 US$169,489
2020-09-21 2020-09-21 PlS Planned sale
2,250 -10.1%
19.74
US$44,415
2,250 -10.1% 19.74 US$44,415
2020-06-23 2020-06-19 PlS Planned sale
15,000 -19.1%
124.00
US$1,860,000
15,000 -19.1% 124.00 US$1,860,000
2020-04-09 2020-04-08 PlS Planned sale
2,407 -3.7%
79.98
US$192,512
2,407 -3.7% 79.98 US$192,512
2020-04-02 2020-04-01 PlS Planned sale
1,537 -2.3%
82.00
US$126,034
1,537 -2.3% 82.00 US$126,034
2020-03-26 2020-03-25 PlS Planned sale
1,618 -2.4%
78.47
US$126,964
1,618 -2.4% 78.47 US$126,964
2020-03-26 2020-03-24 PlS Planned sale
2,041 -2.9%
74.36
US$151,769
2,041 -2.9% 74.36 US$151,769
2019-10-01 2019-09-30 PlS Planned sale
2,375 -9.6%
18.06
US$42,892
2,375 -9.6% 18.06 US$42,892
2019-09-24 2019-09-20 PlS Planned sale
2,250 -11.0%
20.24
US$45,540
2,250 -11.0% 20.24 US$45,540
2019-03-27 2019-03-26 PlS Planned sale
3,656 -7.2%
89.18
US$326,025
3,656 -7.2% 89.18 US$326,025
2019-03-25 2019-03-21 PlS Planned sale
1,930 -3.4%
90.47
US$174,614
1,930 -3.4% 90.47 US$174,614
2019-03-25 2019-03-21 PlS Planned sale
2,589 -4.4%
89.62
US$232,020
2,589 -4.4% 89.62 US$232,020
2019-03-21 2019-03-19 PlS Planned sale
3,728 -5.9%
93.07
US$346,965
3,728 -5.9% 93.07 US$346,965